Drug Class
FLT3 inhibitor
Type
ingredient
Active Ingredient
quizartinib
📋Overview
Quizartinib is a targeted therapy drug classified as a tyrosine kinase inhibitor. It is primarily associated with the treatment of certain types of acute myeloid leukemia (AML), particularly those involving mutations in the FLT3 gene. By blocking specific signals that promote cancer cell growth, quizartinib aims to slow or stop the progression of leukemia. Its use is generally focused on patients with specific genetic profiles within the broader category of blood cancers.
📚References
Information from MedlinePlus.gov (NIH).
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.
Find Discounts for Quizartinib
Hospitals.net Disclosure
Hospitals.net is an independent healthcare information platform and does not provide, administer, or guarantee prescription discounts, pricing, coupons, or pharmacy participation. All discount pricing and availability shown above are provided by RxGo and its partners and are subject to change without notice.
Hospitals.net may receive a commission or referral fee if you choose to use this prescription discount service. This does not affect the price you pay at the pharmacy. Hospitals.net is not responsible for pricing accuracy, pharmacy participation, or the fulfillment of any discount offers.